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Of the approximately 30,000 genes in the
entire human genome, > 1,500 genetic vari-
ants have been discovered in which a single
allele (either as a homozygote or heterozygote)
is sufficient for a single gene or Mendelian
disorder such as Huntington’s disease to
develop (National Center for Biotechnology
Information 2004). However, relatively few
variants have been conﬁrmed for complex dis-
eases such as cancer, heart disease, and diabetes
in which both susceptibility genes and envi-
ronmental contributors are required for the
disease to develop (Botstein and Risch 2003;
Hirschhorn et al. 2002). The slow pace in
identifying and conﬁrming genetic contribu-
tors for complex diseases is due primarily to
the difficulties of detecting relatively weak,
incremental genetic effects as well as to the
possibility that even moderate or strong effects
involving a genetic contributor may require
the co-occurrence of one or more environmen-
tal contributors (Hodgson and Popat 2003).
Similarly, although the identity and func-
tion of some environmental contributors
to complex diseases such as cancer are well
known (toxicants such as asbestos, behaviors
such as smoking, viruses such as human papil-
loma virus), almost all of these known contribu-
tors have been identiﬁed as such because they
have relatively strong effects on disease suscep-
tibility. At the same time, however, a signiﬁ-
cant proportion of environmental contributors
remain unknown for many complex diseases.
For example, only one-third of the breast can-
cer cases in the United States can be accounted
for by known risk factors (Stevens 2002). The
overwhelming remainder involves either candi-
date risk factors that are known but have not
yet been conﬁrmed as such (which raises the
cases accountable to ~50%) or risk factors that
are not recognized as such at all. Moreover,
even already-identiﬁed risk factors for disease
such as diet, tobacco, and hormones each are
composed of complicated combinations of
behaviors and toxicants whose roles in carcino-
genesis are not well understood (Brennan
2002). Smoking, for instance, is a contextually
shaped behavior that can take a variety of often
culturally specific forms as it exposes those
who perform it (and others around them) to
> 300 different toxicants (Chassin et al. 2000;
Frohlich et al. 2002).
In response to these current limitations, a
number of researchers have suggested scaling
up research sample sizes to provide greater
statistical power for identifying and conﬁrming
genetic and environmental contributors to
complex diseases (Caporaso 2002; Collins
2004; Little et al. 2003; Millikan 2002). Efforts
in scaling up sample sizes involve significant
national and private investments in research
infrastructure. Governmental and nonprofit
funding agencies as well as for-proﬁt ventures
in various countries are in the process of plan-
ning or assembling larger scientiﬁc resources to
meet that perceived need.
Some of these larger sample collections
are in the form of prospective cohorts that
recruit healthy participants with the intention
of following their health status over a number
of years. For example, the National Institute
of Child Health and Human Development
along with the National Institute of Environ-
mental Health Sciences, the Centers for
Disease Control and Prevention, and the
U.S. Environmental Protection Agency has
been planning a National Children’s Study
designed to follow 100,000 children and their
parents over multiple decades (National
Children’s Study 2004), and the National
Cancer Institute (NCI) has recently issued a
new call for proposals for funding large
prospective cohorts (NCI 2003). The NCI
already funds the Black Women’s Cohort
(64,500 participants) and the California
Teachers Study (133,479 participants) among
other large prospective studies (NCI 2004).
The NCI announcements of funding for
prospective cohorts explicitly contrast them
with previous investments in cross-sectional
or case–control studies, characterizing cohorts
as more flexible, longer-lasting investments
in research infrastructure. Most recently, the
National Human Genome Research Institute,
in collaboration with the National Heart,
Lung, and Blood Institute, has requested
information from researchers in planning
a national cohort of 500,000 participants
(National Institutes of Health 2004). In
Europe, there is a long tradition of birth
cohort studies that extend decades into adult-
hood, with recent investments in new birth
cohorts by the United Kingdom and plan-
ning for a “mega” cohort by the European
Union (Kogevinas 2002).
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Increasing the size of prospective cohorts and biobanks is one approach to discovering previously
unknown contributors to complex diseases, but it may come at the price of concealing contributors
that are less common across all the participants in those larger studies and of limiting hypothesis
generation. Prospective cohorts and biobanks constitute significant, long-term investments in
research infrastructure that will have ongoing consequences for opportunities in biomedical
research for the foreseeable future. Thus, it is important to think about how these major additions
to research infrastructure can be designed to be more productive in generating hypotheses for novel
environmental contributors to complex diseases and to help identify genetic and environmental
contributors that may not be common across the larger samples but are more frequent within local
or ancestral subsets. Incorporating open-ended inquiries and qualitative information about local
communal and ecologic contexts and the political, economic, and other social structures that affect
health status and outcome will enable qualitative hypothesis generation in those localized contexts,
as well as the collection of more detailed genealogic and family health history information that may
be useful in designing future studies. Using communities as building blocks for larger cohorts and
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Research CommentaryA related kind of resource, often called
biobanks, incorporates members of national or
regional populations for which extensive retro-
spective medical records, DNA samples, and
other health-related information are available
to researchers (Austin et al. 2003). Some
biobanks also function as prospective cohorts.
The deCODE project, for instance, already has
isolated genes that appear to contribute to
osteoporosis, stroke, diabetes, and several other
complex diseases using historical and contem-
porary health information and DNA samples
from more than 100,000 residents of Iceland
(deCODE Genetics 2004), although some of
those ﬁndings may turn out to be limited to
rarer familial factors. Similar biobanks are
being assembled in Estonia (an open-ended
number of participants), the United Kingdom
(500,000 participants), Quebec (60,000 partici-
pants), and Japan (300,000 participants). In
the United States, Howard University has
announced the formation of a biobank with
samples from participants who identify them-
selves as African Americans (Kaiser 2003).
Investments made today in prospective
cohorts and biobanks that are projected to be
used (and funded) for decades to come will
have signiﬁcant consequences for determining
both the opportunities and the limits of future
research into genetic and environmental con-
tributors to complex diseases. Although it will
be possible to establish new cohorts and
biobanks in the future, it will be several years
before prospectively recruited participants
develop diseases of interest in sufﬁcient num-
bers for analysis. Moreover, funding for addi-
tional cohorts in future years will compete
with the costs of maintaining ongoing cohorts,
which likely will limit future growth in this
research infrastructure. Consequently, as
cohorts and biobanks are being planned, it
is important to consider the methodologic
implications that their increased scales may
have for identifying genetic and environ-
mental contributors that may be more locally
variable in effect. Locally variable or less com-
mon contributors nonetheless can have signiﬁ-
cant effects on health disparities, raising
questions about the equitable distribution of
research beneﬁts in the case of large, expensive
cohorts that may not be designed to attend to
smaller-scale contexts.
Is Bigger Always Better?
Although larger cohorts or biobanks likely will
help identify many genetic and environmental
contributors that are more common among
their members, they will be less likely to help
identify those less common contributors that
are rare among most participants. Indeed, the
additional power that a larger cohort provides
to detect weaker common effects simultane-
ously can mask those contributors that are
localized primarily within subsets of the larger
sample, depending on how cohort information
is collected and analyzed. For instance, a genetic
variant that is more frequent among individuals
of a particular ancestry but rare among others
may not be detected in a sample of 100,000
participants recruited using such inclusion crite-
ria as regional or national residence or occupa-
tion. Similarly, an environmental contributor
that is specific to exposures resulting from a
local ecologic feature or a locally speciﬁc behav-
ior also could be lost in a large, multisite cohort,
even though it may be a signiﬁcant determinant
of disease. This means that the ways in which
participants are categorized and recruited for a
particular cohort or biobank and in which their
information is collected and analyzed will affect
what studies using that resource may find as
well as what they may miss.
A criticism of the UK Biobank, for
instance, has been that it has no speciﬁc plans
to incorporate a familial component into its
recruitment strategy (Wright et al. 2002).
Family members (particularly sibling pairs and
parents) provide greater power for separating
genetic effects from the background noise of
nongenetic effects. In addition, there also
tend to be correlations in common environ-
mental and gene–environment interactions
among close relatives compared with random,
unrelated individuals. Thus, the larger size of
a cohort may not necessarily increase its
power to detect genetic or environmental
contributors to complex diseases.
That situation is complicated further by the
possibility that the same complex disease may
have multiple genetic and environmental con-
tributors that are neither necessary nor sufﬁcient
for a similar phenotype to be expressed (Smith
and Lusis 2002). In the cases of type 2 diabetes
and systemic lupus erythematosus, for example,
different candidate genes have been proposed
from studies of geographically and ancestrally
differing patient populations, although some of
those will not be conﬁrmed (Kelly et al. 2002;
Stern 2002). In the case of breast cancer (as for
the vast majority of other cancers), not all con-
firmed environmental contributors need be
present for the disease to develop. With the
additional variable of gene–environment inter-
actions, it may well be that some significant
(although still minority) proportions of the inci-
dence of most complex diseases are attributable
to intersections of locally varying combinations
of genetic and environmental contributors some
or even many of which may not be detectable in
large multisite samples. To the extent that those
polygenic and polyenvironmental contributors
are nonrandomly distributed among and across
populations, a large cohort or biobank may fail
to detect some or even most of these unless it is
structured to support more intensive study of
subsets of participants.
The greater cost of larger cohorts, however,
tends to mean that fewer and often less precise
measures are obtained for each participant, a
situation that actually can reduce the power of
a larger sample (Wong et al. 2003). Sampling
costs also can reduce the ability to collect infor-
mation that is most productive for hypothesis
generation. Because it is expensive to investi-
gate family histories and environmental expo-
sure histories for large numbers of participants
(Barbour 2003), large cohort studies tend to
collect participant information through closed-
ended questions—that is, by giving partici-
pants a range of predetermined answers to
predetermined questions and forcing them to
choose among them (UK Biobank 2002). For
environmental exposures, closed-ended ques-
tions are useful in testing hypotheses about
established or suspected contributors but are of
limited value in identifying previously unsus-
pected contributors whether those are localized
or more common (Foster and Aston 2003).
With respect to ancestry, some studies allow
participants to indicate more than one ethnic
or racial background but without eliciting
additional information that may be more
informative about how genetic variants are
distributed in the extensive middle ground
between immediate family members and large
population categories such as European
American or African American.
These limited, closed-ended responses fre-
quently are used as proxies for a shared popula-
tion history (in the case of ancestry) or for
shared environmental exposures (or both) for
purposes of sample stratiﬁcation. The difﬁculty,
however, is that such broad, decontextualed
proxies often are treated as units of analysis
rather than as heuristic means to disambiguate
or discover speciﬁc ancestral and environmental
contributors to disease or to provide a degree of
diversity within the sample frame.
Identity alone, however, is not causal and
may not even necessarily be predictive. First,
not all factors linked to a given identity neces-
sarily contribute to disease expression or to the
expression of the same diseases. Second, only
some environmental and ancestral factors are
shared among those with a common identity.
Third, only some of those with a common
identity necessarily share those linked factors.
Social identity does become a more powerful
predictor, however, when it intersects with ecol-
ogy in a speciﬁc locality. Sharing both a social
identity and a locality increases the likelihood
that and the extent to which a social commu-
nity will regulate the actions of its members
according to some standard of appropriateness
(and, hence, manifest many of the same behav-
ioral environmental factors), the likelihood that
community members are exposed to many of
the same ambient factors in the physical
environment, and the degree of access to pre-
vention, surveillance, and treatment available to
community members. Locality also may limit
significantly the number of ancestries shared
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hood that some are related by more immediate
genealogic connections.
Communities as Building
Blocks
These critiques suggest that a signiﬁcant chal-
lenge in constructing large-scale cohorts and
biobanks is to design a study with a large num-
ber of participants that nonetheless gathers rich
data on individuals and the contexts that affect
their health, providing ﬂexibility for discover-
ing unanticipated data fields and new cate-
gories within existing ﬁelds. One solution may
be to use the local communities in which
individuals are everyday members—a naturally
occurring social middle ground between single
participants and very large ethnic and other
categories—as building blocks for constructing
large prospective samples. Local communities
also would be appropriate contexts for recruit-
ing parents and siblings to enrich the familial
component of cohorts and biobanks.
Local communities, of course, may be
quite variable in form, ranging from relatively
well-defined residential clusters or towns in
rural areas to neighborhoods or social net-
works within large metropolitan areas. What
defines a localized community, however, is
that its members share similar interactional
conventions, a consequence of their everyday
encounters with one another, as well as simi-
lar ambient or background exposures due to
the local physical environment.
The idea that locality or place may affect
health is not new (Durkheim 1951). However,
the last decade has seen a revival of interest in
theorizing and conceptualizing that relation-
ship (Curtis and Rees-Jones 1998; Kearns and
Joseph 1993; Macintyre et al. 1993; Tunstall
et al. 2004). In contrast with the prevailing
epidemiologic focus on individual risk factors,
this revival has emphasized collective or con-
textual effects that may mediate the effects of
individual-level variables such that the health
status of individuals depends to some extent on
the social and physical environments in which
individuals grow up and live (Schwarz 1994;
Susser 1994). The proponents of this approach
argue that collective or contextual “area effects”
are complex, multilevel interactions involving
phenomena or forces ranging from global,
national, or regional social structures that
determine opportunities and limitations for
well-being (including economic systems and
conditions, health care systems and access,
political structures and equity, and widespread
cultural beliefs and social practices) to more
localized communal beliefs, practices, and con-
ditions to diverse intracommunity patterns of
individual agency (Macintyre et al. 2002;
Popay et al. 1998). Thus, rather than adopt the
traditional epidemiologic practice of isolating
and testing one environmental factor at a time
while attempting to control for the effects of
others, a more appropriate method of analysis
may be to embrace the complexity of multi-
level collective or contextual contributors.
Fine-grained information about contextual
effects in local communities offers two primary
advantages in studies of environmental contrib-
utors to disease susceptibility. First, those data
provide additional background information
that can be used to better interpret responses to
standardized questions, but in ways that still
allow comparison across the larger sample. For
instance, the same ethnic identity or household
income level can indicate differing health risks
and outcomes depending on such locally vari-
able contributors as beliefs about health and ill-
ness, familial and communal social dynamics
and networks, and political and economic
structures (Krieger 2001; Williams 2003). Each
of these parameters (along with others) helps
shape everyday life in ways that can have differ-
ing consequences for behaviors that may expose
individuals to environmental toxins and may
be further differentiated by local variations in
physical environments and the ambient expo-
sures that those offer. Detailed investigations of
these local differences can augment an under-
standing of the pathways by which social and
ecologic factors contribute to disease suscepti-
bility or can explain why a risk factor does not
appear to be as predictive for a specific sub-
population (Frohlich et al. 2001).
Second, detailed local investigations allow
many more opportunities for hypothesis gener-
ation, which then can be tested across the larger
sample. Epidemiologic tests for the statistical
signiﬁcance of associations between established
proxies such as ethnicity or socioeconomic sta-
tus and disease incidence or mortality offer few
opportunities for generating novel hypotheses
about environmental contributors, mainly
because those proxies summarize rather than
disaggregate speciﬁc environmental factors. In
contrast to proxies that summarize information,
a community-speciﬁc approach that produces
large amounts of in-depth information about
a broad range of aspects of everyday life pro-
vides many speciﬁc possibilities for generating
hypotheses (Brown 2003; Thompson and
Gifford 2000). Indeed, generating hypotheses
in small-scale contexts is preferable to doing so
across large multisite samples because the for-
mer is more amenable to qualitative studies of
the different ways in which a large number of
factors interact with one another, whereas the
latter is more suited to testing hypotheses about
a limited number of well-deﬁned, measurable
data points.
One of the primary difficulties in using
large samples to detect gene–environment
interactions is that most nongenetic inﬂuences
are difﬁcult to measure such that they often are
dismissed as being beyond investigation in
large samples (Wright et al. 2002). Rather than
simply ignore those inﬂuences in a larger sam-
ple because they cannot be measured accurately
or efﬁciently using existing metrics, qualitative,
community-speciﬁc approaches offer the possi-
bility of developing a functional understanding
of how their effects are achieved, which may
help develop accurate, efﬁcient measures that
then can be applied in quantitative analyses of
larger samples. For example, qualitative data
gathered using a “life course” approach can be
analyzed to identify biologic and social factors
that affect health throughout life in a cumula-
tive manner (both independently and interac-
tively), develop measures of their effects, and
describe chains or pathways of risk by which
linked exposures raise the likelihood of disease
expression (Ben-Shlomo and Kuh 2002;
Hallqvist et al. 2004; Kuh and Ben-Shlomo
1997; Kuh et al. 2003). Thus, qualitative meth-
ods such as ethnography may become an inter-
disciplinary companion to epidemiology
(Kaufman and Cooper 2001; O’Campo 2003).
Practical and Ethical
Challenges
Taking a community-specific approach does
raise several logistical and ethical issues that
may be problematic. An immediate reaction to
our proposal is likely to be concern about the
additional cost of recruiting participants to
comprise both local community units and the
overall cohort, as well as the additional cost of
in-person elicitation of open-ended ethno-
graphic and genealogic information. However,
given the significant investments already
required by very large prospective cohorts or
retrospective biobanks, incurring additional
costs to enrich the information collected, par-
ticularly with respect to hypothesis generation,
should be seen as enhancing the value of what
will become long-term investments in bio-
medical infrastructure. A less expensive alter-
native could be to recruit some but not all
participants as members of community units,
with the idea that hypothesis generation need
not involve all cohort or biobank participants.
Indeed, community units may be selected
within the larger scale of the study as a whole
in two ways: as models that are representative
of most study participants (and so have a like-
lihood of generating hypotheses that may be
tested quantitatively across most participants
to identify more common contributors) or as
efforts to make the cohort more diverse by
including participants whose identities contain
elements (e.g., ancestry, residence, occupation,
household income) that may evidence some
contributors to disease differing from those
that are more common within the larger
cohort. Both strategies add value to the cohort
as a whole, albeit in different ways.
With respect to the latter strategy, a fre-
quent problem in making a participant pool
more diverse is that including subjects who
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does not necessarily ensure sufﬁcient power to
stratify the sample to quantitatively analyze
the less common contributors that may affect
those more diverse participants. However, by
recruiting some of those minority participants
as members of community units, they can be
oversampled by the greater detail of informa-
tion collected rather than by attempting to
recruit larger numbers of participants who ﬁt
those less common inclusion criteria.
A community-speciﬁc strategy also presents
several ethical challenges. For example, investi-
gators will need to consider when the addi-
tional subject interactions become overly
burdensome on particular populations—for
example, minority communities that may have
been studied extensively in the past. Collecting
large amounts of in-depth data about partici-
pants, family members, and local communities
also presents somewhat greater ethical chal-
lenges than do responses to closed-ended ques-
tions. Although maintaining conﬁdentiality is a
requirement in both cases, it is more difﬁcult
to anticipate the risks that might accrue from
open-ended inquiries. Moreover, gathering
additional information about communities as
wholes and about third-party relatives may
entail the potential for risks to others than just
study participants. For example, published
indications of greater genetic susceptibility to a
disease among individuals of a speciﬁc ancestry
or of greater environmental risks to those who
reside in a particular place or pursue a particu-
lar lifestyle may put those with that ancestry,
residence, or lifestyle at a greater risk for dis-
crimination or stigmatization.
At the same time, community-specific
investigation often creates a stronger relation-
ship between researchers and participants that
should tend to produce greater trust and,
hence, more extensive and accurate responses
as well as reduced attrition in multiyear and
multidecade studies. Emphasizing communi-
ties makes it possible to engage pre-existing
social organizations and networks in evaluating
(and possibly modifying) ethical protections
and recruitment strategies, in assisting in par-
ticipant recruitment and liaison, in actually
collecting some study information, and in
helping construct local interpretations of the
information collected (Sharp and Foster 2000).
This greater attention to local contexts should
result in greater participant inﬂuence in shap-
ing how research is done and greater investiga-
tor awareness of local community needs.
Conclusion
The future of biomedical research should
reside both in “small science” and in “big 
science.” The two approaches are not necessar-
ily mutually exclusive, although the larger
scale of the latter may limit the scale of infor-
mation that is collected from participants. We
believe that larger cohorts and biobanks need
not preclude smaller, ﬁner-grained investiga-
tions of community-speciﬁc inﬂuences on dis-
ease. In fact, qualitative, community-speciﬁc
investigations are not only possible within the
context of those increasingly large-scale inves-
tigations but can provide opportunities for
additional hypothesis generation as well as
facilitate the multilevel analysis of individual,
contextual, and structural factors that con-
tribute to complex diseases.
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